Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease

48Citations
Citations of this article
126Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control. In patients with Parkinson's disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced dyskinesias (LID). This paper analyzed the pathophysiology, clinical manifestations, pharmacological treatments, and surgical procedures to treat hyperkinetic disorders. Surgery is currently the only treatment available for Parkinson's disease that may improve both parkinsonian motor syndrome and LID. However, this paper shows the different mechanisms involved are not well understood. © 2012 J. Guridi et al.

Cite

CITATION STYLE

APA

Guridi, J., González-Redondo, R., & Obeso, J. A. (2012). Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson’s disease. Parkinson’s Disease. https://doi.org/10.1155/2012/943159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free